Skip to content

Corbadrine

Drug profile

Also known as: (-)-alpha-(1-Aminoethyl)-3,4-dihydroxybenzyl alcohol, levoepinefrina, levonordefrin

OfmFDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Corbadrine is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1960. DrugCentral lists 4 molecular targets, including Adra2b|Adra2c|Adra2a, ADRA1D and Adra1b|Adra1d|Adra1a.

  • Approval status: ofm (first approved 1960 by the FDA).
  • Molecular targets: Adra2b|Adra2c|Adra2a, ADRA1D, Adra1b|Adra1d|Adra1a and ADRA2A|ADRA2B|ADRA2C (4 listed in DrugCentral).
  • Molecular formula: C9H13NO3; molecular weight 183.21 g/mol.

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Adrenergic receptor alpha-2Adra2b|Adra2c|Adra2aunknownKi 6.69
Alpha-1D adrenergic receptorADRA1DagonistKi 5.60
Adrenergic receptor alpha-1Adra1b|Adra1d|Adra1aunknownKi 5.44
Adrenergic receptor alpha-2ADRA2A|ADRA2B|ADRA2Cagonist—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1960-01-06FDA—EASTMAN KODAK

Chemical structure

Molecular formulaC9H13NO3
Molecular weight183.21 g/mol
CAS number—
InChIKeyGEFQWZLICWMTKF-CDUCUWFYSA-N
PubChem CID164739
C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Corbadrine work?

Its molecular targets in DrugCentral include Adra2b|Adra2c|Adra2a, ADRA1D (agonist), Adra1b|Adra1d|Adra1a and ADRA2A|ADRA2B|ADRA2C (agonist).

When was Corbadrine first approved?

Corbadrine was first approved by the FDA in 1960.

What is the chemical formula of Corbadrine?

Corbadrine has the molecular formula C9H13NO3 and a molecular weight of 183.21 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1960-01-06
AgencyFDA
Targets4
Indications0
FormulaC9H13NO3
DrugCentral ID4482
Interactive profile